Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
Onoda S, Masuda N, Seto T, Eguchi K, Takiguchi Y, Isobe H, Okamoto H, Ogura T, Yokoyama A, Seki N, Asaka-Amano Y, Harada M, Tagawa A, Kunikane H, Yokoba M, Uematsu K, Kuriyama T, Kuroiwa Y, Watanabe K; Thoracic Oncology Research Group Study 0301.
Onoda S, et al. Among authors: okamoto h.
J Clin Oncol. 2006 Dec 1;24(34):5448-53. doi: 10.1200/JCO.2006.08.4145.
J Clin Oncol. 2006.
PMID: 17135647
Clinical Trial.